Výsledky vyhledávání - Nadir Cheurfa

  • Zobrazuji výsledky 1 - 4 z 4
Upřesnit hledání
  1. 1
    Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences

    Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences Autor Daniela A.F. Ferrarezi, Nadir Cheurfa, André F. Reis, Frédéric Fumeron, Gilberto Velho

    Vydáno 2007
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study

    Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance... Autor Nadir Cheurfa, Guilherme Marasciulo Brenner, André F. Reis, D. Dubois-Laforgue, Ronan Roussel, Jean Tichet, Olivier Lantieri, Beverley Balkau, Frédéric Fumeron, José Timsit, Michel Marre, Gilberto Velho

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    The Common −866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men

    The Common −866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men Autor Nadir Cheurfa, Danièle Dubois‐Laforgue, Daniela A.F. Ferrarezi, André F. Reis, Guilherme Marasciulo Brenner, C. Bouché, Claude Le Feuvre, Frédéric Fumeron, José Timsit, Michel Marre, Gilberto Velho

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

    Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label,... Autor J. Guigay, Cécile Ortholan, Damien Vansteene, Didier Cupissol, Caroline Even, Marie‐Christine Kaminsky, C. Sire, Emmanuel Blot, P. Debourdeau, Laurence Bozec, Esma Saâda-Bouzid, Jérôme Fayette, Pierre Dalloz, Y. Pointreau, H. Le Caer, Claire Falandry, Laurence Digue, A. Braccini, S. López, Pierre Guillet, Cécile Michel, Nadir Cheurfa, Dominique Schwob, Jean Bourhis, C. Mertens, Anne Aupérin

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: